skip to main content

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > organooxygen compound > ester > carboxylic ester > lactone > cyclodepsipeptide > n-[(3s,6s,7r,10s,15r)-15-benzyl-10-[(2s)-butan-2-yl]-3,7,13,13-tetramethyl-2,5,9,12,14-pentaoxo-1,4,8,11-tetraoxacyclopentadec-6-yl]benzamide
... > organooxygen compound > carbonyl compound > carboxylic ester > lactone > cyclodepsipeptide > n-[(3s,6s,7r,10s,15r)-15-benzyl-10-[(2s)-butan-2-yl]-3,7,13,13-tetramethyl-2,5,9,12,14-pentaoxo-1,4,8,11-tetraoxacyclopentadec-6-yl]benzamide
organooxygen compound > ester > lactone > cyclodepsipeptide > n-[(3s,6s,7r,10s,15r)-15-benzyl-10-[(2s)-butan-2-yl]-3,7,13,13-tetramethyl-2,5,9,12,14-pentaoxo-1,4,8,11-tetraoxacyclopentadec-6-yl]benzamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > peptide > depsipeptide > cyclodepsipeptide > n-[(3s,6s,7r,10s,15r)-15-benzyl-10-[(2s)-butan-2-yl]-3,7,13,13-tetramethyl-2,5,9,12,14-pentaoxo-1,4,8,11-tetraoxacyclopentadec-6-yl]benzamide
... > organooxygen compound > carboxamide > peptide > depsipeptide > cyclodepsipeptide > n-[(3s,6s,7r,10s,15r)-15-benzyl-10-[(2s)-butan-2-yl]-3,7,13,13-tetramethyl-2,5,9,12,14-pentaoxo-1,4,8,11-tetraoxacyclopentadec-6-yl]benzamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > peptide > depsipeptide > cyclodepsipeptide > n-[(3s,6s,7r,10s,15r)-15-benzyl-10-[(2s)-butan-2-yl]-3,7,13,13-tetramethyl-2,5,9,12,14-pentaoxo-1,4,8,11-tetraoxacyclopentadec-6-yl]benzamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic amino compound > peptide > depsipeptide > cyclodepsipeptide > n-[(3s,6s,7r,10s,15r)-15-benzyl-10-[(2s)-butan-2-yl]-3,7,13,13-tetramethyl-2,5,9,12,14-pentaoxo-1,4,8,11-tetraoxacyclopentadec-6-yl]benzamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organic amino compound > peptide > depsipeptide > cyclodepsipeptide > n-[(3s,6s,7r,10s,15r)-15-benzyl-10-[(2s)-butan-2-yl]-3,7,13,13-tetramethyl-2,5,9,12,14-pentaoxo-1,4,8,11-tetraoxacyclopentadec-6-yl]benzamide

Preferred term

n-[(3s,6s,7r,10s,15r)-15-benzyl-10-[(2s)-butan-2-yl]-3,7,13,13-tetramethyl-2,5,9,12,14-pentaoxo-1,4,8,11-tetraoxacyclopentadec-6-yl]benzamide  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

Broader concept

charge

  • 0

formula

  • C33H39NO10

inchi

  • InChI=1S/C33H39NO10/c1-7-19(2)26-31(39)41-20(3)25(34-28(36)23-16-12-9-13-17-23)30(38)42-21(4)29(37)43-24(18-22-14-10-8-11-15-22)27(35)33(5,6)32(40)44-26/h8-17,19-21,24-26H,7,18H2,1-6H3,(H,34,36)/t19-,20+,21-,24+,25-,26-/m0/s1

inchikey

  • FAZZMEBXTMSOJN-ZIIXUDKGSA-N

mass

  • 609.672

monoisotopicmass

  • 609.25740

smiles

  • O=C1O[C@H](C(=O)O[C@@H]([C@H](NC(=O)C2=CC=CC=C2)C(=O)O[C@H](C(O[C@@H](C(C1(C)C)=O)CC3=CC=CC=C3)=O)C)C)[C@H](CC)C

subset

  • 2_STAR

synonym EXACT

  • N-[(3S,6S,7R,10S,15R)-15-benzyl-10-[(2S)-butan-2-yl]-3,7,13,13-tetramethyl-2,5,9,12,14-pentaoxo-1,4,8,11-tetraoxacyclopentadec-6-yl]benzamide

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:225699

Download this concept: